ReadyCell first successful shipment to China
Oct
19
And more news related to the expansion of ReadyCell in Asia: For the first time in the history of ReadyCell S.L., we have completed a successful shipment to China from our facilities in Spain. China is definitely a potential market for Drug Discovery, and we are glad to say that we are building and consolidating relevant partnerships in order to increase our presence and technologies in one of the biggest economies worldwide. Every time more than
ReadyCell first shipment to South Korea
Oct
02
ReadyCell team is pleased to announce that we have completed a successful large distance shipment from our production facilities in Spain to South Korea, a new market for us with a lot of potential. We are happy to slowly being recognized in Asian countries such as Japan and India, and now as well in South Korea. Wherever you are based is not inconvenient for getting our kits in your facilities. Thanks to our Shipping Medium,
Participating in the Nordic Life Science Days 2018 in Stockholm, Sweden
Sep
12
Going to Stockholm to meet the life science industry ReadyCell has started the last quarter of 2018 participating in the Nordic Life Science Days conference, taking place in Stockholm (Sweden) between the 10th and 12th of September 2018. Nordic Life Science Days has grown rapidly since its launch in 2012 to become the largest Nordic Partnering Conference for the global Life Science Industry, with a strong presence of Pharma, Biotech and CRO companies from the
ReadyCell is proud to receive Nexel in Barcelona
Aug
23
Receiving South Korean partner in Barcelona The Readycell team was glad to welcome Nexel’s CEO Dr. Choonseong Han, and Nexel’s Business Manager, Dr. Hayden Lee to visit our facilities in the city of Barcelona in July 2018. Nexel is a biotechnology company based in Seoul, S. Korea, an expert in producing iPSC derived cell-products for in-vitro toxicology screenings. ReadyCell and Nexel first met in Boston in the context of the BioUSA conference, and both companies’
Participating in DDI 2018 in Seattle, USA
Jun
27
Crossing the Atlantic for excellent R&D ReadyCell is committed to keep track of new developments and tendencies within the early drug discovery process, thus we were really glad and excited to participate in to this year’s DDI 2018 conference held in Seattle, between the 14th and 16th of June 2018. Our colleague Dr. Maria Vázquez attended the conference, and met with relevant scientists from many Pharma, Biotech and Academia and discussed the new scenarios within
Participating in BIOUSA 2018 in Boston, USA
Jun
14
Developing new trans-Atlantic partnerships June of 2018 has been an important month for ReadyCell, due to our participation in this year’s BIO International Convention held in the city of Boston, Massachusetts, during the 4th – 7th of June. Our colleague Gerard Palau had the chance to meet with Spanish representatives in the Spanish Pavilion, and also, he has met with a remarkable number of scientists, Business Developers, and CEO’s of different Pharma, Biotech and CRO
ReadyCell first shipment to New Zealand
Apr
23
Looking for an innovative and sophisticated cell-based ready-to-use kit for your permeability and active transport studies? ReadyCell S.L. team is pleased to announce that just today we have completed a successful large distance shipment from our production facilities in Spain to New Zealand. Whatever you are based is not inconvenient for getting our kits in your facilities. Thanks to our Shipping Medium, a novel patented system for in vitro cell preservation, ReadyCell team is capable
HEPNOU PROJECT
Mar
21
R&D Projects: developing different products based on the same cellular origin The main objective for this project involves the completion of the set of HepatoReady products, iniciated in 2014 (Project financed by ACCIÓ, numer RD14 1-0087) and includes the following technical objectives: 1. Develop a method that allows isolated hepatocyte cryopreservation from human tissue, that constitutes a better option for their long term storage, and it offers a permanent supply of product. 2. Develop a
Incorporation of new Business Development Manager
Jan
09
A growing staff for a growing business And yet more news for ReadyCell. We are also really proud to announce another new incorporation, Naiara Valtierra, as a Business Development Manager at ReadyCell. Naiara is a young but yet experienced biotechnologist with an outstanding background in clinical research and in Business Development. You too, Naiara, welcome on board!
Incorporation of new R&D Manager
Dec
05
Expanding R&D staff and activities ReadyCell is pleased to announce its newest member Dr. María Vázquez-Sánchez, who joins ReadyCell team as a Head of R&D. Within her role, María will support the development of new in-vitro, ready-to-use tools, for ADME/DMPK studies. Welcome on board, María!
Participating in BioJapan 2017 in Yokohama
Oct
08
Internationalization is a core value of our business ReadyCell’s representatives participated in the BioJapan 2017 held in Yokohama (11-13 October) in order to meet local and international companies to penetrate the Japanese market with our unique shipping technologies and ready-to-use kits for ADME studies. We would like to thank ACCIÓ and ASEBIO for supporting ReadyCell during this journey and for helping us meet interesting companies during our stay, and also to the organizers to allow
Business Trip to the United Kingdom
May
18
Crossing the Channel to show our added value ReadyCell committed to visit key customers and potential new clients in the British territory, in order to raise awareness of our existing products as well as to receive feedback from Key Opinion Leaders from the Bioscience sectors. ReadyCell’s representatives will travel to important UK cities such as Nottingham, Cambridge and London, and visit companies such as Sygnature Discovery, Pharmaron UK, and Astex Therapeutics as key companies in
ReadyCell Partnering in China
May
09
Developing new international partnerships After different contacts along 2013, last month ReadyCell visited several companies during a Chinese tour. With the aim to promote its implantation in the Asian market, and being a hub for R&D and CRO services, Shanghai and Beijing were the cities chosen for this partnering trip. ReadyCell representatives met CEOs, CSOs and ADME Directors from key Chinese companies as Wuxi App Tec, Joinn Laboratories, Shanghai Medicilon and PharmaLegacy. Thanks to ReadyCell
ReadyCell at ADME & Predictive Toxicology Meeting
Feb
20
Join us at the Annual ADME & Predictive Toxicology meeting in Barcelona Select Biosciences organized the 7th Annual ADME & Predictive Toxicology meeting in Barcelona, and ReadyCell participated with a poster presentation in the event. During the meeting (18-19th Feb, Barcelona) ReadyCell presented some preliminary results regarding Solid Shipping Medium new applications. Francisco Torres, Sales Manager and Scientific advisor attended to the meeting with a poster showing how Ready-to-Use technology could be eventually applied to
ReadyCell at “The In Vitro Choice” Meeting
Dec
20
ReadyCell speaking at The In Vitro Choice Josep Oriol Nicolás, ex-CEO at ReadyCell, participated as speaker in the PCB meeting “The In Vitro Choice” with the talk “Trends and Challenges in the Drug Discovery sector”. The speakers list included basic researchers and companies responsibles in the field of safety and toxicity assays. Dr. Nicolas joined David Ramos (Ceretox), Mª Pilar Vinardell (Univ. Barcelona), Judit Sendra (Endor Nanotechnologies), Maria Dusinska (NILU), Ellen Fritsche (IUF), Marta Barenys
ReadyCell visits India as part of Catalan Commercial Mission
Dec
09
ReadyCell going to India to develop new business opportunities. ReadyCell joined two weeks ago a catalan commercial mission organized by ACCIÓ. During this business trip, ReadyCell representative Francisco Miguel Torres (Sales Manager and Scientific Advisor) visited many Indian top pharmaceutical companies, discussing their potential needs in the ADME-Tox segment and different partering oportunities. ReadyCell also participated in three different B2B events (Delhi, Mumbai and Bangalore), broading its contact network within the indian market and establishing
ReadyCell joins Catalonia Bio
Dec
08
ReadyCell has recently joined Catalonia Bio the Catalan Association of Biotechnologic Companies. Catalonia Bio offers to its members many partnering opportunities, and a cooperative and integrative platform to achieve different government business stimulating initiatives. As a trade association, Catalonia Bio is also a global representative of the Biotechnology company field. In addition to this announcement, an interview to ReadyCell’s CEO (Dr. Josep Oriol Nicolás) was published in the website of Catalonia Bio (no longer available).
ReadyCell will attend CPhI Worlwide
Oct
20
Meet ReadyCell at CPhI Worlwide! ReadyCell will attend to the CHpI Worldwide convention in Frankfurt (22-24 October 2013). This is the world’s leading pharmaceutical networking event, and is co-located with many other interesting events such ICSE, P-MEC and InnoPack. CHpI will host over 30,000 attendees from 140 countries and 2,200 exhibitors, and is a key meeting point for pharmaceutical companies. Find out more information in the official website: CHpI Worldwide
CacoReady Batch #500 Released!
Oct
01
Congratulations to ReadyCell’s Production Team for achieving the release of the batch number 500 of CacoReady kits! Last week orders will receive the batch 500, an astonishing achievement accomplished thanks to years of high quality manufacturing and service, result of our Production mates efforts. Marta, Anna, Alberto and Sheila (from left to right) compose the Production department and are the responsible for the top quality ready-to-use kits commercialized from ReadyCell. This very experienced team is